BIOQuébec is celebrating the Québec government’s newly introduced balanced budget for 2017-2018, which contains elements to support the value creation of the biotechnology and life sciences industry.
Read More
MassBio’s 2017 Annual Meeting is this week! Will you be attending?
Read More
BIOQuébec and Pharmed are hosting this forum on contract research organizations (CROs) in 2017. Benefit from a $100 discount off the regular price of $395!
Read More
The Institut national d’excellence en santé et services sociaux (INESSS) recommended to use an affordable genetic screening test to avoid cases where patients experience complications following the Xeloda chemotherapy treatment, commonly known as 5-FU in its intravenously administered form.
Read More
Morphine and Fentanyl addiction, the cause of hundreds of overdose deaths in the country, could become a thing of the past.
Read More
Immuno-oncology has become increasingly prominent in the medical research industry.
Read More
Pierre Falardeau, VP of BIOQuébec’s Board of Directors, will be a lecturer at GRUM’s 3rd Scientific Symposium.
Read More
The need for easier access to funding for SMBs was an increasingly popular topic in both politics and finance recently.
Read More
By June, GIPTIS will invite 10-12 companies to be part of its new public-private health organization and cooperation model in France.
Read More
The industry is quite strong in Québec, and Montréal InVivo hopes to distinguish itself even further.
Read More
Rytvela article among the top 10% of articles of The Journal of Immunology
Read More
Biotechs base themselves on everyday life to find innovative solutions to various challenges to human health and well-being through the use of cutting-edge technology.
Read More
While the arrival of Quark Venture brings new opportunities to the biotechnology industry, will its investments help improve the longevity of biotech firms in Vancouver?
Read More
During its trade mission to Switzerland which occurred earlier this month, BIOQuébec formalized its partnership with Health Valley to facilitate business ties between their respective members.
Read More
CRISPR-Cas9 will now allow researchers to correct genetic mutations at the origins of hereditary diseases, to make blood cells more resistant to HIV, and much more…
Read More
BIOQuébec and Biron Health Group have entered into a partnership to promote the positive impacts of Québec’s life sciences innovations.
Read More
BIOQuébec and Biotech Finances have joined forces to promote Québec’s life sciences companies within the Francophonie while also updating our local organizations on francophone businesses around the world who are in the same industry.
Read More
